Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inhibition, Psychological × AZD1390 × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 3 Sarcoma 1 Recurrence 1 Neoplasm Metastasis 1 Meningeal Neoplasms 1 Inhibition, Psychological 1 Hereditary Sensory and Autonomic Neuropathies 1 Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

tazemetostat 1 osimertinib 1 itacitinib 1 Radiotherapy 1 INCB039110 1 AZD1390 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03423628 2025-12-22

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

AstraZeneca

Phase 1 Recruiting

Brain Neoplasms, Glioblastoma, Inhibition, Psychological, Meningeal Neoplasms, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡